Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 2Small Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Leiomyosarcoma 1Ichthyosis, X-Linked 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Doxorubicin 13Specimen Handling 12pembrolizumab 11Magnetic Resonance Spectroscopy 10Biopsy 10Cyclophosphamide 9X-Rays 7Ifosfamide 7Radiotherapy 6Phantoms, Imaging 6Gemcitabine 6liposomal doxorubicin 5Nivolumab 5tazemetostat 4palbociclib 4fludarabine 4atezolizumab 4Temozolomide 4Radiation 4Nuclear Medicine Department, Hospital 4Irinotecan 4larotrectinib 3cabozantinib 3Surveys and Questionnaires 3Ipilimumab 3Carboplatin 3Bevacizumab 3ulixertinib 2tipifarnib 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × ADI PEG20 × 90 days × Clear all
NCT05712694 2026-04-20

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Polaris Group

Phase 3 Recruiting
300 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma

NCT05813327 2026-04-20

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Washington University School of Medicine

Phase 1 Active not recruiting
6 enrolled
Sarcoma

Sarcoma, Ichthyosis, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡